about
Long sleep duration associated with a higher risk of increased arterial stiffness in males.Fluid overload, pulse wave velocity, and ratio of brachial pre-ejection period to ejection time in diabetic and non-diabetic chronic kidney disease.Comprehensive Care for People With Diabetic Kidney DiseaseDesign and methods of CYCLE-HD: improving cardiovascular health in patients with end stage renal disease using a structured programme of exercise: a randomised control trial.Results and lessons from the Spironolactone To Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (STOP-CKD) randomised controlled trial.Matrix Gla-Protein (MGP) Not Only Inhibits Calcification in Large Arteries But Also May Be Renoprotective: Connecting the DotsSignificant Correlation between Brachial Pulse Pressure Index and Renal Resistive Index.Novel therapeutic approaches to chronic kidney diseaseEnd Stage Renal Disease as a Potential Risk Factor for Retinal Vein Occlusion.Deterioration in renal function is associated with increased arterial stiffness.Effect of A Reduction in glomerular filtration rate after NEphrectomy on arterial STiffness and central hemodynamics: rationale and design of the EARNEST study.Role of Vitamin D in Uremic Vascular Calcification.The serum- & glucocorticoid-inducible kinase in the regulation of platelet function.Cardiovascular Autonomic Dysfunction in Chronic Kidney Disease: a Comprehensive Review.The importance of accurate measurement of aortic stiffness in patients with chronic kidney disease and end-stage renal disease.A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.The Safety of Erythropoiesis-Stimulating Agents for the Treatment of Anemia Resulting from Chronic Kidney Disease.A propitious time for initiating clinical trials in patients with heart failure with reduced ejection fraction and an estimated glomerular filtration rate <30 mL/min with an mineralocorticoid receptor antagonist and a K+ binder: 'the forbidden fruitPredicting decline of kidney function in lupus nephritis using urine biomarkers.New insights in molecular mechanisms involved in chronic kidney disease using high-resolution plasma proteome analysis.Caveolin-1 single-nucleotide polymorphism and arterial stiffness in non-dialysis chronic kidney disease.Comparison between Cystatin C- and Creatinine-Estimated Glomerular Filtration Rate in Cardiology Patients.A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial.The association between the apolipoprotein B/A-I ratio and coronary calcification may differ depending on kidney function in a healthy population.Central pulse pressure in patients with chronic kidney disease and in renal transplant recipients.Does decreased mean platelet volume predict inflammation in chronic renal failure, dialysis, and transplanted patients?Routine kidney variables, glomerular filtration rate and urinary cystatin C in cats with diabetes mellitus, cats with chronic kidney disease and healthy cats.Premature Coronary Artery Disease and Early Stage Chronic Kidney Disease.Impact of hemodialysis, left ventricular mass and FGF-23 on myocardial mechanics in end-stage renal disease: a three-dimensional speckle tracking study.High-Density Lipoprotein in Chronic Kidney Diseases-The Devil Is in the Detail.Predictors of aortic pulse wave velocity in the elderly with severe aortic stenosis.Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm SVascular calcification and renal bone disorders
P2860
Q33894535-D3A0612F-8BA2-4F95-A32C-23FE24B61199Q34489116-A31E89BE-4278-466F-8C25-CEEBE4FA48FBQ35953885-9B64A77B-B579-458D-8C0E-DB0FA662A03CQ36071494-83CDF2D0-7328-4528-B9A3-3E8F70D7C299Q36625246-1A1AC3F2-7B16-4C90-B7BA-268164597A9AQ36645711-B3FFC8AA-AAC1-4CA2-AA81-5D8B9FD37402Q36721450-B629BD85-C200-4364-95AD-BF19F441F642Q37219032-7E173847-6C48-44D1-B43E-60EAD12491C6Q37328492-1BA7490C-8E74-4B9B-A2A9-00D04DFA9B66Q37409789-112D0C63-BAD7-4355-A76E-BF927D272FBCQ37522761-2D14186F-25DE-4FF2-BE2D-333CAE65ED8CQ37670797-832E7789-E3CF-469D-958F-BA35E6C16804Q38221746-ABDF4C00-4D4E-4FA4-9DAA-801B39D21514Q38527010-87154BC1-2666-48A1-BCB4-4D21A7990DABQ38635835-94423402-D4B3-4295-8F7D-D30194337090Q38638652-BFFFFD94-6167-4E14-B79F-39DC9FB5E73CQ38740871-04215A6D-A6DB-4DE2-9C62-27A22188B65FQ38880170-2CE9E55E-5D14-47DE-B93F-C63C03E3CEC3Q38908585-03926A36-E66A-4B33-B86D-B63BD2514B16Q38986294-D21E2CCD-429F-469A-BF72-9BF16781A6A8Q40471430-38C12C15-E92D-42B0-8ECA-EAA9A6EFD215Q41835085-29129FFB-30CD-43CF-AF75-2088660E1285Q42026773-3337E66A-6A1D-4F28-8E5C-D2F49DB5D9A1Q42366242-49E44B3C-BF15-49C0-8A75-2CAF41EB320FQ43860910-CBC0E084-4328-4A73-914B-B281C475E1CBQ46172532-DE4262BB-5A3D-43D3-B310-AB80948C3F6EQ49034688-97E72087-D67C-4769-ADAF-5D655A9735DFQ50099911-08064F03-2CAD-49D3-9FF7-142B28457B58Q50613899-8F3CEAF0-9680-4270-97E2-F96605141AF7Q52374541-AC386D3F-70FF-42B1-8F3E-B7ABCBC746A9Q53789829-3615A008-4677-4681-8026-2861CD35D173Q58492145-BBA49EEA-379C-40F6-A94A-A1510E639EF6Q59100578-4EAE5B61-F853-45A1-AB2F-A8DE3E74DB48
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Arterial disease in chronic kidney disease.
@en
type
label
Arterial disease in chronic kidney disease.
@en
prefLabel
Arterial disease in chronic kidney disease.
@en
P2093
P1433
P1476
Arterial disease in chronic kidney disease
@en
P2093
Colin D Chue
Nicola C Edwards
William E Moody
P304
P356
10.1136/HEARTJNL-2012-302818
P407
P577
2012-10-31T00:00:00Z